Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025
Data confirmed TX45’s tolerability profile and improvements in left ventricular function and…
Brain Cancer Canada Awards $68,000 Research Grant for Clinical Trial of Anti-Cancer Vaccine Targeting DIPG, the Most Aggressive Pediatric Brain Cancer
TORONTO, May 17, 2025 (GLOBE NEWSWIRE) -- Today, on DIPG Awareness Day,…
Avance Clinical Honored with Frost & Sullivan’s 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services
This award recognizes Avance Clinical's strategic innovation, operational agility, and unwavering commitment to…
Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments
US economic strategist and hedge fund manager Ronen Israel appointed Board Director,…
Madrigal Announces New Clinical Data Demonstrating Rezdiffra (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the…
Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barr Syndrome (GBS) at the 2025 PNS Meeting
May 09, 2025 17:00 ET | Source: Annexon Biosciences First Oral Presentation…
Osstem, the World’s No. 1 in Implant Sales Volume, Pioneers India’s future of implantology with High-quality products and Clinical trainings
SEOUL, South Korea, May 8, 2025 /PRNewswire/ -- Osstem Implant, a global…
Endogenex Highlights 48-Week REGENT-1 Clinical Study Results at Digestive Disease Week 2025
Novel Endoscopic Procedure Demonstrates Substantial and Durable Reduction in Insulin Resistance and…
Axtria Launches LUCCID to Transform Clinical Data Management with GenAI
Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy…
BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47)
April 28, 2025 04:00 ET | Source: BlackfinBio CHESHIRE, United Kingdom, April…